Medtronic, Inc. (MDT) PT Lowered to $140 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Medtronic, Inc. (MDT) PT Lowered to $140 at Stifel
November 24, 2021 8:05 AM EST
Guggenheim analyst Chris Pasquale lowered the price target on Medtronic, Inc. (NYSE: MDT) to $142.00 (from $148.00) while maintaining a Buy rating.
The analyst commented, "MDT reported FY2Q22 revenue below Consensus estimates, though relatively in-line with weakened sentiment, in our view, while adj.... More
November 23, 2021 1:27 PM EST
Needham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $145.00 (from $152.00) while maintaining a Buy rating.
The analyst commented, "MDT's F2Q22 revenue missed consensus while EPS beat consensus and organic revenue growth slowed to 2.2% from 19.0% in... More
November 23, 2021 6:46 AM EST
Medtronic (NYSE: MDT) reported Q2 EPS of $1.32, $0.03 better than the analyst estimate of $1.29. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.96 billion.
GUIDANCE:
Medtronic sees FY2022 EPS of $5.65-$5.75, versus the consensus of $5.71.
The company today updated its revenue growth guidance and reiterated...
More
